jrnl3462

Publication Venue For

  • Self-endorsed cognitive problems versus objectively assessed cognitive impairment in blood or bone marrow transplantation recipients: A longitudinal study..  126:2174-2182. 2020
  • Bereaved parents' views on end-of-life care for children with cancer: Quality marker implications. 2020
  • Patient-reported outcomes in the Translational Breast Cancer Research Consortium.  126:922-930. 2020
  • Association between facility volume and mortality of patients with classic Hodgkin lymphoma.  126:757-764. 2020
  • End-of-life care among adolescent and young adult patients with cancer living in poverty.  126:886-893. 2020
  • Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children’s Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.  126:593-601. 2020
  • Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: A Bayesian network meta-analysis of phase 3 randomized controlled trials 2020
  • Bias and stereotyping among research and clinical professionals: Perspectives on minority recruitment for oncology clinical trials.  126:1958-1968. 2020
  • Body fat indices and survival in immunotherapy-treated patients with cancer 2020
  • Cause-specific mortality in survivors of adolescent and young adult cancer 2020
  • Pain in older survivors of hematologic malignancies after blood or marrow transplantation: A BMTSS report.  126:2003-2012. 2020
  • Biomarkers in ovarian cancer: To be or not to be.  125:4563-4572. 2019
  • Inclusiveness and ethical considerations for observational, translational, and clinical cancer health disparity research.  125:4452-4461. 2019
  • Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study.  125:4442-4451. 2019
  • Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation.  125:4498-4508. 2019
  • Effects of cancer history on functional age and mortality.  125:4303-4309. 2019
  • Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report.  125:4033-4042. 2019
  • Underutilization of guideline-recommended supportive care among older adults with multiple myeloma in the United States.  125:4084-4095. 2019
  • Intent and subsequent initiation of human papillomavirus vaccine among young cancer survivors.  125:3810-3817. 2019
  • Providing health care for patients with childhood cancer and survivors: A survey of pediatric primary care providers.  125:3864-3872. 2019
  • Racial and ethnic disparities in neurocognitive, emotional, and quality-of-life outcomes in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.  125:3666-3677. 2019
  • Increasing the use of active surveillance for prostate cancer in younger men.  125:3292-3295. 2019
  • Medicare and patient spending among beneficiaries diagnosed with chronic myelogenous leukemia.  125:2570-2578. 2019
  • Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.  125:2027-2038. 2019
  • Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.  125:1459-1469. 2019
  • Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma—Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.  125:1373-1383. 2019
  • Hispanic ethnicity as a moderator of the effects of aerobic and resistance exercise in survivors of breast cancer.  125:910-920. 2019
  • Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.  125:921-932. 2019
  • Health care use during cancer survivorship: Review of 5 years of evidence.  125:673-680. 2019
  • Unmet social support needs among older adults with cancer.  125:473-481. 2019
  • Vigorous physical activity and mental health—Associations suggest a link among childhood cancer survivors.  125:2923-2925. 2019
  • The antitumor effects of entinostat in ovarian cancer require adaptive immunity.  124:4657-4666. 2018
  • Risk of cardiovascular disease among Nordic childhood cancer survivors with diabetes mellitus: A report from adult life after childhood cancer in Scandinavia.  124:4393-4400. 2018
  • Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis.  124:4231-4240. 2018
  • Congestive heart failure in older adults diagnosed with follicular lymphoma: A population-based study.  124:4221-4230. 2018
  • Costs of cancer along the care continuum: What we can expect based on recent literature.  124:4181-4191. 2018
  • Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma.  124:4211-4220. 2018
  • A home-based mentored vegetable gardening intervention demonstrates feasibility and improvements in physical activity and performance among breast cancer survivors.  124:3427-3435. 2018
  • Access to gynecologic oncology care and the network adequacy standard.  124:2677-2679. 2018
  • Inpatient utilization and disparities: The last year of life of adolescent and young adult oncology patients in California.  124:1819-1827. 2018
  • Reply to Evaluation of magnetic resonance imaging and targeted biopsy: The difficulty of finding the right reference standard.  124:1300-1301. 2018
  • Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.  124:1150-1159. 2018
  • Prevalence of anthracycline-related cardiac dysfunction in long-term survivors of adult-onset lymphoma.  124:850-857. 2018
  • Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.  124:617-625. 2018
  • Most impactful factors on the health-related quality of life of a geriatric population with cancer.  124:596-605. 2018
  • Radiation therapy utilization in Medicare beneficiaries with early-stage breast cancer.  124:475-481. 2018
  • Multi-institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12-core systematic biopsy.  124:278-285. 2018
  • C-MYC–positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional “hits” and outcomes with subsequent therapy.  123:4411-4418. 2017
  • Supporting cancer family caregivers: How can frontline oncology clinicians help?.  123:3212-3215. 2017
  • Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.  123:3141-3149. 2017
  • The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.  123:2762-2772. 2017
  • Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.  123:2472-2481. 2017
  • Factors predicting prostate cancer upgrading on magnetic resonance imaging–targeted biopsy in an active surveillance population.  123:1941-1948. 2017
  • Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosis.  123:769-782. 2017
  • Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non–small cell lung tumors.  123:688-696. 2017
  • Cervical cancer screening: How do we make sense of it all and what is the right balance?.  122:3596-3597. 2016
  • Expression of p16INK4A in cervical precancerous lesions is unlikely to be preventable by human papillomavirus vaccines.  122:3615-3623. 2016
  • Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).  122:3464-3471. 2016
  • Impact of marital status, insurance status, income, and race/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States.  122:3183-3190. 2016
  • Patient-centered support in the survivorship care transition: Outcomes from the Patient-Owned Survivorship Care Plan Intervention.  122:3232-3242. 2016
  • Accuracy of urinary human papillomavirus testing for the presence of cervical human papillomaviruses and higher grades of cervical intraepithelial neoplasia.  122:2836-2844. 2016
  • Improving the quality of survivorship for older adults with cancer.  122:2459-2568. 2016
  • Ototoxicity and cancer therapy.  122:1647-1658. 2016
  • A note on the magnitude of hazard ratios.  122:1298-1299. 2016
  • Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco.  122:1150-1159. 2016
  • Reply to a note on the magnitude of hazard ratios.  122:1299-1300. 2016
  • Looking back to inform the future: Lesson learned from survivors of childhood cancer.  122:678-680. 2016
  • Physical activity communication between oncology providers and patients with early-stage breast, colon, or prostate cancer.  122:470-476. 2016
  • Childhood cancer survivorship research in minority populations: A position paper from the childhood cancer survivor study.  122. 2016
  • Concurrent chemoradiotherapy versus radiotherapy alone for “biopsy-only” glioblastoma multiforme.  122:2364-2370. 2016
  • Group trajectory analysis helps to identify older cancer survivors who benefit from distance-based lifestyle interventions.  121:4433-4440. 2015
  • Diet quality of cancer survivors and noncancer individuals: Results from a national survey.  121:4212-4221. 2015
  • Impact of care at comprehensive cancer centers on outcome: Results from a population-based study.  121:3885-3893. 2015
  • Nonbiological factors affecting survival in younger patients with acute myeloid leukemia.  121:3877-3884. 2015
  • How much do cancer-related symptoms contribute.  121:2831-2839. 2015
  • Cognitive predictors of understanding treatment decisions in patients with newly diagnosed brain metastasis.  121:2013-2019. 2015
  • Health-related quality of life in lung cancer survivors: Latent class and latent transition analysis.  121:1520-1528. 2015
  • Economic hardship of minority and non-minority cancer survivors 1 year after diagnosis: Another long-term effect of cancer?.  121:1257-1264. 2015
  • Antioxidant micronutrients and the risk of renal cell carcinoma in the Women's Health Initiative cohort.  121:580-588. 2015
  • Cancer survivors' uptake and adherence in diet and exercise intervention trials: An integrative data analysis.  121:77-83. 2015
  • Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.  121:648-663. 2015
  • Impact of colorectal cancer diagnosis and treatment on health-related quality of life among older Americans: A population-based, case-control study.  121:943-950. 2015
  • Piecing together the puzzle of disparities in adolescents and young adults.  121:1168-1171. 2015
  • Predictors of colorectal cancer surveillance among survivors of childhood cancer treated with radiation: A report from the Childhood Cancer Survivor Study.  121:1856-1863. 2015
  • Daughters and Mothers Against Breast Cancer (DAMES): Main outcomes of a randomized controlled trial of weight loss in overweight mothers with breast cancer and their overweight daughters.  120:2522-2534. 2014
  • Adherence and retention in clinical trials: a community-based approach..  120 Suppl 7:1106-1112. 2014
  • An overview of EMPaCT and fundamental issues affecting minority participation in cancer clinical trials: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual..  120 Suppl 7:1087-1090. 2014
  • Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement..  120 Suppl 7:1113-1121. 2014
  • Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia.  120:955-962. 2014
  • Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT)..  120 Suppl 7:1097-1105. 2014
  • State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual..  120 Suppl 7:1122-1130. 2014
  • Evaluating comparative effectiveness with observational data: Endoscopic ultrasound and survival in pancreatic cancer.  119:3861-3869. 2013
  • Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancer..  119:3653-3661. 2013
  • Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer.  119:3359-3366. 2013
  • Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.  119:3385-3392. 2013
  • The relation between cancer patient treatment decision-making roles and quality of life.  119:2342-2349. 2013
  • Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer: Translational Breast Cancer Research Consortium trial 017.  119:1776-1783. 2013
  • Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: A prospective case series of 960 patients.  119:1495-1502. 2013
  • Chemotherapy use and patient treatment preferences in advanced colorectal cancer.  119:854-862. 2013
  • Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.  119:774-781. 2013
  • A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306).  118:5601-5607. 2012
  • Clinical significance of KISS1 protein expression for brain invasion and metastasis.  118:2096-2105. 2012
  • Weight management and its role in breast cancer rehabilitation.  118:2277-2287. 2012
  • Pretreatment and routine echocardiogram monitoring during chemotherapy for anthracycline-induced cardiotoxicity rarely identifies significant cardiac dysfunction or alters treatment decisions: A 5-year review at a single pediatric oncology center.  118:1919-1924. 2012
  • Disparities in cancer screening in individuals with a family history of breast or colorectal cancer.  118:1656-1663. 2012
  • Erratum: Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy (Cancer (2010) 116 (5517-26)).  117:5021. 2011
  • Examination of laryngoesophageal dysfunction-free survival as an endpoint in nonsurgical treatment of squamous cell carcinomas of the larynx and hypopharynx.  117:4447-4451. 2011
  • Racial variation in willingness to trade financial resources for life-prolonging cancer treatment.  117:3476-3484. 2011
  • The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.  117:1602-1611. 2011
  • Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method.  117:1386-1398. 2011
  • A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia.  117:1253-1261. 2011
  • A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia.  117:957-963. 2011
  • Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.  116:5517-5526. 2010
  • A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas.  116:5297-5305. 2010
  • Ethnic differences in chronic health conditions after hematopoietic cell transplantation: A report from the bone marrow transplant survivor study.  116:4152-4159. 2010
  • Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice.  116:3862-3874. 2010
  • Prognostic value of mucin 4 expression in colorectal adenocarcinomas.  116:3577-3586. 2010
  • Cervical cancer prevention: New tools and old barriers.  116:2531-2542. 2010
  • Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status..  116:2645-2654. 2010
  • Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?.  116:1535-1544. 2010
  • Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.  116:1367-1377. 2010
  • Variations in gastric cancer care: A trend beyond racial disparities.  116:465-475. 2010
  • Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer.  115:5798-5806. 2009
  • The role of angiocidin in sarcomas.  115:5251-5262. 2009
  • Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation.  115:4127-4135. 2009
  • Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors.  115:4001-4009. 2009
  • Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver.  115:3360-3368. 2009
  • Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.  115:2119-2127. 2009
  • Timing of consent for the research use of surgically removed tissue is postoperative consenting acceptable?.  115:4-9. 2009
  • Health care utilization by adult Hispanic long-term survivors of hematopoietic stem cell transplantation: Report from the Bone Marrow Transplant Survivor Study.  113:2724-2733. 2008
  • Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: Follow-Up of a Children's Oncology Group cohort.  113:2597-2604. 2008
  • Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation.  113:1580-1587. 2008
  • Hip bone density predicts breast cancer risk independently of gail score: Results from the women's health initiative.  113:907-915. 2008
  • Large, clear cytoplasmic vacuolation : An under-recognized cytologic clue to distinguish solid pseudopapillary neoplasms of the pancreas from pancreatic endocrine neoplasms on fine-needle aspiration.  114:249-254. 2008
  • Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQ01 in patients who developed anthracycline-related congestive heart failure after childhood cancer.  112:2789-2795. 2008
  • Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: A report from the Childhood Cancer Survivor Study.  112:2071-2079. 2008
  • Proxy perspectives regarding end-of-life care for persons with cancer.  112:1854-1861. 2008
  • Proxy perspectives about end-of-life care 2008
  • Neoadjuvant docetaxel treatment for locally advanced prostate cancer: A clinicopathologic study.  110:1248-1254. 2007
  • Significance and possible causes of false-negative results of reflex human papillomavirus infection testing.  111:154-159. 2007
  • Education predicts quality of life among men with prostate cancer cared for in the department of veterans affairs: A longitudinal quality of life analysis from CaPSURE.  109:1769-1776. 2007
  • Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire.  109:1914-1922. 2007
  • Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells.  109:1279-1289. 2007
  • Tyrosine kinase receptor RON in human pancreatic cancer: Expression, function, and validation as a target.  109:1030-1039. 2007
  • Impact of HPV testing, HPV vaccine development, and changing screening frequency on national pap test volume: Projections from the National Health Interview Survey (NHIS).  111:34-40. 2007
  • Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells.  107:2425-2435. 2006
  • Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma.  107:2282-2290. 2006
  • The Deep South Network for cancer control: Building a community infrastructure to reduce cancer health disparities.  107:1971-1979. 2006
  • Therapeutic role of lymph node resection in endometrioid corpus cancer: A study of 12,333 patients.  107:1823-1830. 2006
  • Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia.  107:1303-1312. 2006
  • Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian cancer: A cost-effectiveness analysis.  107:536-543. 2006
  • Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma.  107:371-379. 2006
  • Fine-needle aspiration biopsy of hepatic lesions: Computerised tomographic-guided versus endoscopic ultrasound-guided FNA.  108:180-185. 2006
  • Probabilistic reporting of EUS-FNA cytology: Toward improved communication and better clinical decisions.  108:93-101. 2006
  • Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: Results from the bone marrow transplant survivor study.  106:1402-1408. 2006
  • Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: The impact of the 2001 Bethesda System.  108:39-44. 2006
  • Reflex human papilloma virus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2-3 in young versus elderly women.  105:194-198. 2005
  • Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.  104:427-438. 2005
  • Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly.  103:2349-2354. 2005
  • High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas.  103:2163-2170. 2005
  • Survivors of childhood cancer and their guardians: Current health behaviors and receptivity to health promotion programs.  103:2171-2180. 2005
  • Diagnostic procedures after a positive spiral computed tomography lung carcinoma screen.  103:157-163. 2005
  • Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma [2] (multiple letters).  101:2899. 2004
  • Endoscopic ultrasound-guided fine-needle aspiration biopsy of the adrenal glands: Analysis of 24 patients.  102:308-314. 2004
  • Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): Results from cancer and leukemia group B study 8461 and review of the literature.  101:1420-1427. 2004
  • Endoscopic ultrasound-guided fine-needle aspiration biopsy: A powerful tool to obtain samples from small lesions.  102:239-246. 2004
  • Endoscopic ultrasound-guided fine-needle aspiration in the diagnosis of foregut duplication cysts: The value of demonstrating detached ciliary tufts in cyst fluid.  102:253-258. 2004
  • Initial treatment of melanoma brain metastases using gamma knife radiosurgery: An evaluation of efficacy and toxicity.  101:825-833. 2004
  • Oncolysis by viral replication and inhibition of angiogenesis by a replication-conditional herpes simplex virus that expresses mouse endostatin.  101:869-877. 2004
  • Establishing the multidisciplinary care of patients with cancer in the state of Delaware.  101:220-225. 2004
  • Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma.  101:66-76. 2004
  • Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound-guided fine-needle aspiration biopsy.  102:157-163. 2004
  • Adoptive Immunotherapy with Allogeneic Epstein-Barr Virus (EBV)-Specific Cytotoxic T-Lymphocytes for Recurrent, EBV-Positive Hodgkin Disease.  100:1892-1901. 2004
  • MUC1 and MUC2 Expression in Pancreatic Ductal Carcinoma Obtained by Fine-Needle Aspiration.  99:365-371. 2003
  • Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma: Emphasis on atypical, suspicious, and false-negative aspirates.  99:285-292. 2003
  • Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: The importance of tumor length and lymph node status.  95:1434-1443. 2002
  • Endoscopic ultrasound-guided fine-needle aspiration biopsy: A study of 103 cases.  96:232-239. 2002
  • Model prediction of treatment planning for dose-fractionated radioimmunotherapy..  94:1264-1269. 2002
  • Rationales, evidence, and design considerations for fractionated radioimmunotherapy..  94:1332-1348. 2002
  • Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector..  94:1298-1305. 2002
  • Identification of higher risk thin melanomas should be based on Breslow depth not Clark Level IV.  91:983-991. 2001
  • Reducing the cost of diagnosis of breast carcinoma: Impact of ultrasound and imaging-guided biopsies on a clinical breast practice.  91:324-332. 2001
  • Statewide Tuskegee Alliance for clinical trials. A community coalition to enhance minority participation in medical research..  91:237-241. 2001
  • The accumulation of ascorbic acid by squamous cell carcinomas of the lung and larynx is associated with global methylation of DNA.  89:171-176. 2000
  • National cancer data base survey of breast cancer management for patients from low income zip codes.  88:933-945. 2000
  • Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas.  88:674-684. 2000
  • Second primary tumors in patients with cutaneous malignant melanoma.  86:2014-2020. 1999
  • Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma.  86:1159-1164. 1999
  • Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma..  86:1159-1164. 1999
  • The role of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma: Seeking to optimize local control and survival while minimizing toxicity.  86:195-196. 1999
  • The role of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma: seeking to optimize local control and survival while minimizing toxicity..  86:195-196. 1999
  • Cryopreservation of sperm from patients with leukemia: Is it worth the effort?.  85:1973-1978. 1999
  • Cryopreservation of sperm from patients with leukemia: is it worth the effort?.  85:1973-1978. 1999
  • Transforming growth factor-β differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up-regulation of p21(WAF1).  85:1810-1815. 1999
  • Gastrointestinal autonomic nerve tumors in the pediatric population: A report of four cases and a review of the literature.  85:220-230. 1999
  • Nuclear accumulation of p53 in colorectal adenocarcinoma prognostic importance differs with race and location of the tumor.  83:2456-2467. 1998
  • Regional diversity and breadth of the National Cancer Data Base.  83:2649-2658. 1998
  • The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States.  83:1262-1273. 1998
  • Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma.  83:989-1001. 1998
  • Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma.  83:490-497. 1998
  • Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma..  83:490-497. 1998
  • Possible mechanisms mediating an association between physical activity and breast cancer.  83:621-628. 1998
  • Possible mechanisms mediating an association between physical activity and breast cancer..  83:621-628. 1998
  • Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina.  83:320-330. 1998
  • Factors associated with the use of flexible sigmoidoscopy as a screening test for the detection of colorectal carcinoma by primary care physicians.  82:1476-1481. 1998
  • The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma.  82:1037-1048. 1998
  • The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study..  82:1037-1048. 1998
  • Cerebrospinal fluid cytology in patients with cancer: Minimizing false- negative results.  82:733-739. 1998
  • Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2..  80:2576-2582. 1997
  • Experimental tumor targeting with radiolabeled ligands..  80:2371-2377. 1997
  • Imaging for improved prediction of myelotoxicity after radioimmunotherapy..  80:2558-2566. 1997
  • Impact of splenomegaly on therapeutic response and I-131-LYM-1 dosimetry in patients with B-lymphocytic malignancies..  80:2553-2557. 1997
  • Synthesis of bombesin analogues for radiolabeling with rhenium-188..  80:2354-2359. 1997
  • Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin-releasing peptide receptor by an adenoviral vector..  80:2419-2424. 1997
  • Long-term follow-up of three randomized trials comparing idarubicin and daunorubicin as induction therapies for patients with untreated acute myeloid leukemia.  80:2181-2185. 1997
  • The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement.  80:1399-1408. 1997
  • The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement..  80:1399-1408. 1997
  • Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma.  80:676-680. 1997
  • Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma..  80:676-680. 1997
  • Pleuropulmonary blastoma: A clinicopathologic study of 50 cases.  80:147-161. 1997
  • Classification of localized melanoma by the exponential survival trees method.  79:1122-1128. 1997
  • Classification of localized melanoma by the exponential survival trees method..  79:1122-1128. 1997
  • Pituitary carcinoma: A clinicopathologic study of 15 cases.  79:804-812. 1997
  • Pituitary carcinoma: a clinicopathologic study of 15 cases..  79:804-812. 1997
  • Mixed connective tissue disease and radiation toxicity: A case report.  79:612-618. 1997
  • Evaluation of factors potentially associated with inadequate follow-up of mammographic abnormalities.  77:2070-2076. 1996
  • Radiation therapy for glottic cancer using 6-MV photons.  77:381-386. 1996
  • Radiation therapy for glottic cancer using 6-MV photons..  77:381-386. 1996
  • Radiation therapy for glottic cancer using 6-MV photons [5].  78:183-183a. 1996
  • Younger women with breast carcinoma have a poorer prognosis than older women.  77:97-103. 1996
  • Younger women with breast carcinoma have a poorer prognosis than older women [3].  78:1517-1518. 1996
  • Long term results of a phase I/II study of aggressive chemotherapy and sequential upper and lower hemibody radiation for patients with extensive stage small cell lung cancer..  76:406-412. 1995
  • A national population‐based study of incidence of colorectal cancer and age. Implications for screening in older Americans.  75:775-781. 1995
  • A phase III randomized, doúble‐blind, multiinstitutional trial of vaccinia melanoma oncolysate‐active specific immunotherapy for patients with stage II melanoma.  75:34-42. 1995
  • Aspirin and reduced risk of esophageal carcinoma.  76:1116-1119. 1995
  • Long term results of a phase I/II study of aggressive chemotherapy and sequential upper and lower hemibody radiation for patients with extensive stage small cell lung cancer.  76:406-412. 1995
  • Prophylactic cranial irradiation in limited‐stage small cell lung cancer.  75:1302-1309. 1995
  • T lymphocytes infiltrating advanced grades of cervical neoplasia. CD8‐positive cells are recruited to invasion.  76:1411-1415. 1995
  • The national cancer data base report on prostate cancer.  75:136-138. 1995
  • The National Cancer Data Base. Report on melanoma..  74:782-788. 1994
  • A peptide-based bifunctional chelating agent for 99mTc- and 186Re-labeling of monoclonal antibodies..  73:769-773. 1994
  • Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3)..  73:1012-1022. 1994
  • Overview of radiation myelotoxicity secondary to radioimmunotherapy using 131I-Lym-1 as a model..  73:1038-1048. 1994
  • Radioiodination of monoclonal antibodies D612 and 17-1A with 3-iodophenylisothiocyanate and their biodistribution in tumor-bearing nude mice..  73:808-815. 1994
  • Sensitization of radiolabeled monoclonal antibody therapy using bromodeoxyuridine..  73:999-1005. 1994
  • A peptide‐based bifunctional chelating agent for 99mtc‐ and 186re‐labeling of monoclonal antibodies.  73:769-773. 1994
  • Comparative toxicity studies of yttrium‐90 mx‐dtpa and 2‐it‐bad conjugated monoclonal antibody (bre‐3).  73:1012-1022. 1994
  • Overview of radiation myelotoxicity secondary to radioimmunotherapy using 131 i‐lym‐1 as a model.  73:1038-1048. 1994
  • Overview of the biology and management of ductal carcinoma in situ of the breast.  74:350-361. 1994
  • Radioiodination of monoclonal antibodies d612 and 17‐1a with 3‐lodophenylisothiocyanate and their biodistribution in tumor‐bearing nude mice.  73:808-815. 1994
  • Sensitization of radiolabeled monoclonal antibody therapy using bromodeoxyuridine.  73:999-1005. 1994
  • The national cancer data base. Report on melanoma.  74:782-788. 1994
  • Three‐dimensional reconstruction of monoclonal antibody uptake in tumor and calculation of beta dose‐rate nonuniformity.  73:912-918. 1994
  • Chemotherapy for pilocytic astrocytomas..  71:3165-3172. 1993
  • Ewing sarcoma of bone in infants and toddlers. A clinicopathologic report from the Intergroup Ewing's Study..  71:2109-2118. 1993
  • Adjuvant therapy for localized prostate cancer.  71:1005-1013. 1993
  • Brain metastasis as the site of relapse in germ cell tumor of testis.  72:2182-2185. 1993
  • Chemotherapy for pilocytic astrocytomas.  71:3165-3172. 1993
  • Comparison of intermittent ondansetron versus continuous infusion metoclopramide used with standard combination antiemetics in control of acute nausea induced by cisplatin chemotherapy.  72:583-586. 1993
  • Ewing sarcoma of bone in infants and toddlers. A clnicopathologic report from the intergroup Ewing's study.  71:2109-2118. 1993
  • Malignant tracheoesophageal fistula in patients with esophageal cancer.  72:1513-1521. 1993
  • The cooperative human tissue network. An update.  71:1391-1394. 1993
  • Declining mortality rates for cancer of the rectum in the United States: 1940‐1985.  70:2597-2601. 1992
  • 18F‐2‐deoxy‐2‐fluoro‐D‐glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron‐emission tomography.  67:1544-1550. 1991
  • Leiomyosarcoma of bone. A ciinicopathologic, immunohistochemical, and ultrastructural study of five cases.  67:1051-1056. 1991
  • Severe 5‐fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome.  68:499-501. 1991
  • Stage IV neuroblastoma in infants. Long‐term survival.  67:1493-1497. 1991
  • Weight gain with breast cancer adjuvant treatment.  67:1954-1959. 1991
  • Prophylactic glutamine protects the intestinal mucosa from radiation injury.  66:62-68. 1990
  • Radiotherapy as an adjunct in the management of merkel cell carcinoma.  65:60-64. 1990
  • Experimental model for locally recurring mammary tumors. Development, morphology, karyotype, growth kinetics, and experimental metastatic potential.  63:1353-1362. 1989
  • Prognosis in stage D‐1 prostate cancer relative to anatomic sites of nodal metastases.  64:1743-1746. 1989
  • Special communication. The cooperative human tissue network.  63:1452-1455. 1989
  • The pathogenesis and clinical significance of cytologically detectable oral Candida in acute leukemia..  62:2042-2046. 1988
  • Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically..  61:2077-2082. 1988
  • Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically.  61:2077-2082. 1988
  • The management of vaginal melanoma.  62:2066-2072. 1988
  • Primary Ewing's sarcoma involving the bones of the head and neck..  60:2829-2840. 1987
  • Is modified radical neck dissection only a staging procedure?.  59:994-999. 1987
  • Differential retention of rhodamine 123 by avian sarcoma virus‐induced glioma and normal brain tissue of the rat in vivo.  59:266-270. 1987
  • Is modified radical neck dissection only a staging procedure?.  59:994-999. 1987
  • Primary Ewing's sarcoma involving the bones of the head and neck.  60:2829-2840. 1987
  • An excess of uterine sarcomas after pelvic irradiation..  58:2003-2007. 1986
  • Beta-chain human chorionic gonadotropin-producing leiomyosarcoma of the small intestine..  58:131-135. 1986
  • A southeastern cancer study group phase I/II trial with vaccinia melanoma oncolysates.  57:649-655. 1986
  • Alternating sequential combination chemotherapy in the management of advanced Hodgkin's disease: A southeastern cancer study group trial.  58:1963-1968. 1986
  • An excess of uterine sarcomas after pelvic irradiation.  58:2003-2007. 1986
  • Beta‐chain human chorionic gonadotropin‐producing leiomyosarcoma of the small intestine.  58:131-135. 1986
  • Combined chemotherapy, radiation, and surgery for epithelial cancer of the anal canal.  57:525-529. 1986
  • Granulocytic sarcoma with an indolent course and destructive skeletal disease. Tumor characterization with immunologic markers, electron microscopy, cytochemistry, and cytogenetic studies.  57:1005-1010. 1986
  • Treatment of chronic lymphocytic leukemia using chlorambucil and prednisone with or without cycle‐active consolidation chemotherapy .A southeastern cancer study group trial.  58:1185-1192. 1986
  • The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma..  55:1398-1402. 1985
  • The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma.  55:1398-1402. 1985
  • Autonomous cholesterol biosynthesis in murine hepatoma. A receptor defect with normal coated pits.  54:1562-1568. 1984
  • Childhood liposarcoma. Report of a case and review of the literature.  54:579-584. 1984
  • Effects of amphotericin B on combination chemotherapy of metastatic sarcomas.  53:214-218. 1984
  • Prospective randomized reappraisal of 5‐fluorouracil in metastatic colorectal carcinoma a comparative trial with 6‐thioguanine.  53:2610-2614. 1984
  • Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients..  51:2152-2156. 1983
  • Acid phosphatase in prostatic tissue homogenates from patients with benign prostatic hyperplasia and prostatic carcinoma.  52:155-160. 1983
  • Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease.  52:2209-2213. 1983
  • Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients.  51:2152-2156. 1983
  • Results of a uniform histopathologic review system of lymphoma cases a ten‐year study from the southeastern cancer study group.  52:675-679. 1983
  • A randomized comparison of cyclophosphamide, DTIC with or without piperazinedione in metastatic malignant melanoma.  49:1355-1357. 1982
  • A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patients with clinically localized melanoma (Stage I): Prognostic factors analysis and preliminary results of immunotherayp.  49:1079-1084. 1982
  • Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experience.  49:2192-2196. 1982
  • A randomized comparative trial of chemotherapy and irradiation therapy for stage ii breast cancer.  47:2833-2839. 1981
  • Antibodies to mouse mammary tumor virus‐related antigen in sera of patients with breast carcinoma.  47:2696-2703. 1981
  • Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of bacillus calmette‐guerin (MER) in advanced breast cancer: A randomized trial by the piedmont oncology association.  47:2295-2301. 1981
  • Combination chemotherapy with and without the methanol‐extracted residue of bacillus calmette‐guerin (MER) in extensive non‐small‐cell lung cancer: A prospective randomized study for the piedmont oncology association.  47:2827-2832. 1981
  • Cyclophosphamide versus cyclophosphamide, methotrexate, and 5‐fluorouracil in advanced prostatic cancer: A randomized trial.  47:1949-1953. 1981
  • Gastric cytomegalovirus infection in bone marrow transplant patients: An indication of generalized disease.  48:1478-1483. 1981
  • Immunoblastic lymphoma: An immunologic study.  47:2312-2318. 1981
  • Metastatic sarcomas: Chemotherapy with adriamycin, cyclophosphamide, and methotrexate alternating with actinomycin D, DTIC, and vincristine.  47:457-465. 1981
  • Predictive ability of lukes‐collins classification for immunologic phenotypes of childhood non‐Hodgkin lymphoma: An institutional series and literature review.  48:2070-2075. 1981
  • Selected prognostic variables for mammographic parenchymal patterns.  47:2135-2137. 1981
  • Subcategories of histiocytic lymphoma: Associations with survival and reproducibility of classification. The southeastern cancer study group experience.  48:2464-2474. 1981
  • Thoracic and elective brain irradiation with concomitant or delayed multiagent chemotherapy in the treatment of localized small cell carcinoma of the lung: A randomized prospective study by the southeastern cancer study group.  47:2407-2413. 1981
  • Combination chemotherapy with cyclophosphamide, adriamycin, intermediate dose methotrexate, and folinic acid rescue (CAMF) in advanced lung cancer.  45:1-5. 1980
  • The effects of exogenous estrogen replacement therapy of the breast: Breast cancer risk and mammographic parenchymal patterns.  45:3027-3033. 1980
  • Chemotherapy versus chemoimmunotherapy in advanced adenocarcinoma of the colon and rectum. A prospective randomized study.  43:91-96. 1979
  • Cyclophosphamide plus 5‐(3,3‐dimethyl‐1‐triazeno)‐imidazole‐4‐carboxamide (DTIC) with or without corynebacterium parvum in metastatic malignant melanoma.  44:899-905. 1979
  • Metastatic carcinoma to the tongue. A report of two cases and a review of the literature.  43:386-389. 1979
  • The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma.  44:406-413. 1979
  • Unusual manifestations of non‐Hodgkin's lymphoma.  44:269-272. 1979
  • BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's disease.  42:2101-2110. 1978
  • Histologic grading of wilms' tumor as a potential prognostic factor: Results of a retrospective study of 26 patients.  41:1199-1207. 1978
  • Lymphocyte mediated reactivity against malignant melanoma detected by a microcytotoxicity assay employing technetium‐99m labeled target cells.  41:2174-2182. 1978
  • A comparison of cyclophosphamide, adriamycin, 5‐fluorouracil (CAF) and cyclophosphamide, methotrexate, 5‐fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer. A southeastern cancer study group project.  40:625-632. 1977